Compare Quest Diagnostics Inc (DGX) vs Jabil Inc (JBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Jabil Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Jabil Inc trades at $365.99 (market cap $37.37B). The key difference: Jabil Inc is the larger of the two by market cap, and Quest Diagnostics Inc pays the higher dividend (1.45%). Which is the better fit depends on your goals.
| DGX | JBL | |
|---|---|---|
Market Cap | $26.21B | $37.37B |
Sector | Health | Technology |
52-Week High | $238.50 | $385.50 |
52-Week Low | $173.49 | $192.49 |
Enterprise Value | $31.97B | $39.90B |
Dividend Yield | 1.45% | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →
